COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany
- PMID: 33180830
- PMCID: PMC7660518
- DOI: 10.1371/journal.pone.0242127
COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany
Abstract
Background: Reported mortality of hospitalised Coronavirus Disease-2019 (COVID-19) patients varies substantially, particularly in critically ill patients. So far COVID-19 in-hospital mortality and modes of death under state of the art care have not been systematically studied.
Methods: This retrospective observational monocenter cohort study was performed after implementation of a non-restricted, dynamic tertiary care model at the University Medical Center Freiburg, an experienced acute respiratory distress syndrome (ARDS) and extracorporeal membrane-oxygenation (ECMO) referral center. All hospitalised patients with PCR-confirmed SARS-CoV-2 infection were included. The primary endpoint was in-hospital mortality, secondary endpoints included major complications and modes of death. A multistate analysis and a Cox regression analysis for competing risk models were performed. Modes of death were determined by two independent reviewers.
Results: Between February 25, and May 8, 213 patients were included in the analysis. The median age was 65 years, 129 patients (61%) were male. 70 patients (33%) were admitted to the intensive care unit (ICU), of which 57 patients (81%) received mechanical ventilation and 23 patients (33%) ECMO support. Using multistate methodology, the estimated probability to die within 90 days after COVID-19 onset was 24% in the whole cohort. If the levels of care at time of study entry were accounted for, the probabilities to die were 16% if the patient was initially on a regular ward, 47% if in the intensive care unit (ICU) and 57% if mechanical ventilation was required at study entry. Age ≥65 years and male sex were predictors for in-hospital death. Predominant complications-as judged by two independent reviewers-determining modes of death were multi-organ failure, septic shock and thromboembolic and hemorrhagic complications.
Conclusion: In a dynamic care model COVID-19-related in-hospital mortality remained very high. In the absence of potent antiviral agents, strategies to alleviate or prevent the identified complications should be investigated. In this context, multistate analyses enable comparison of models-of-care and treatment strategies and allow estimation and allocation of health care resources.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria.Anaesth Crit Care Pain Med. 2020 Oct;39(5):553-561. doi: 10.1016/j.accpm.2020.04.001. Epub 2020 Apr 9. Anaesth Crit Care Pain Med. 2020. PMID: 32278670 Free PMC article.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Lancet Respir Med. 2020. PMID: 32105632 Free PMC article.
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. PMID: 32406927 Free PMC article. Updated.
-
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270. JAMA Netw Open. 2020. PMID: 32543702 Free PMC article. Review.
Cited by
-
Exploring heterogeneity in reported venous thromboembolism risk in COVID-19 and comparison to other viral pneumonias: a systematic review and meta-regression.Res Pract Thromb Haemost. 2023 Jul 13;7(5):102146. doi: 10.1016/j.rpth.2023.102146. eCollection 2023 Jul. Res Pract Thromb Haemost. 2023. PMID: 37663366 Free PMC article.
-
Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis.PLoS One. 2021 May 6;16(5):e0251170. doi: 10.1371/journal.pone.0251170. eCollection 2021. PLoS One. 2021. PMID: 33956882 Free PMC article.
-
Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells.Life Sci Alliance. 2022 Feb 2;5(5):e202201371. doi: 10.26508/lsa.202201371. Print 2022 May. Life Sci Alliance. 2022. PMID: 35110370 Free PMC article.
-
Neutralizing Antibody Therapeutics for COVID-19.Viruses. 2021 Apr 7;13(4):628. doi: 10.3390/v13040628. Viruses. 2021. PMID: 33916927 Free PMC article. Review.
-
In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation.PLoS One. 2021 Feb 3;16(2):e0245772. doi: 10.1371/journal.pone.0245772. eCollection 2021. PLoS One. 2021. PMID: 33534813 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous